Europe's PRAC starts ibuprofen safety review

17 June 2014 - Deborah Wilkes

Archived

The European Union's Pharmacovigilance Risk Assessment Committee (PRAC) is evaluating the cardiovascular risk of taking systemic ibuprofen medicines at high doses over long periods of time. The safety review will also assess the interaction of ibuprofen with low-dose aspirin.

Click tags below for more information on topics:

MHRA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: